AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer. (2018)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/all.13311
PubMed Identifier: 28921585
Publication URI: http://europepmc.org/abstract/MED/28921585
Type: Journal Article/Review
Volume: 73
Parent Publication: Allergy
Issue: 2
ISSN: 0105-4538